WallStreetZenWallStreetZen

NASDAQ: PLUR
Pluri Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their PLUR stock forecasts and price targets.

Forecast return on equity

Is PLUR forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is PLUR forecast to generate an efficient return on assets?

Company
-53.26%
Industry
27.89%
PLUR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

PLUR earnings per share forecast

What is PLUR's earnings per share in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$2.75
Avg 2 year Forecast
-$1.94

PLUR revenue forecast

What is PLUR's revenue in the next 2 years based on estimates from 3 analysts?

Avg 1 year Forecast
$2.6M+98.87%
Avg 2 year Forecast
$10.4M+683.48%
PLUR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

PLUR revenue growth forecast

How is PLUR forecast to perform vs Biotechnology companies and vs the US market?

Company
98.87%
Industry
12,155.84%
Market
1,548.38%
PLUR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
PLUR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

PLUR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
PLUR$3.48N/AN/A
HOWL$0.66$4.67+604.98%Strong Buy
SKYE$1.01$15.00+1,385.15%Buy
KYNB$7.88$43.00+445.69%Buy
PSTV$0.23$6.75+2,834.78%Strong Buy
View Top Biotech Stocks

Pluri Stock Forecast FAQ

What is PLUR's earnings growth forecast for 2026-2027?

(NASDAQ: PLUR) Pluri's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 202.24%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 3,205.53%.

Pluri's earnings in 2026 is -$22,551,000.On average, 3 Wall Street analysts forecast PLUR's earnings for 2026 to be -$25,485,232, with the lowest PLUR earnings forecast at -$24,485,811, and the highest PLUR earnings forecast at -$26,234,798.

In 2027, PLUR is forecast to generate -$17,934,052 in earnings, with the lowest earnings forecast at -$17,230,756 and the highest earnings forecast at -$18,461,525.

If you're new to stock investing, here's how to buy Pluri stock.

What is PLUR's revenue growth forecast for 2026-2027?

(NASDAQ: PLUR) Pluri's forecast annual revenue growth rate of 98.87% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 12,155.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,548.38%.

Pluri's revenue in 2026 is $1,326,000.On average, 3 Wall Street analysts forecast PLUR's revenue for 2026 to be $24,402,526, with the lowest PLUR revenue forecast at $23,440,121, and the highest PLUR revenue forecast at $25,115,076.

In 2027, PLUR is forecast to generate $96,138,736 in revenue, with the lowest revenue forecast at $92,363,146 and the highest revenue forecast at $98,961,175.

What is PLUR's forecast return on assets (ROA) for 2026-2027?

(NASDAQ: PLUR) forecast ROA is -53.26%, which is lower than the forecast US Biotechnology industry average of 27.89%.

What is PLUR's Earnings Per Share (EPS) forecast for 2026-2027?

(NASDAQ: PLUR) Pluri's current Earnings Per Share (EPS) is -$3.12. On average, analysts forecast that PLUR's EPS will be -$2.75 for 2026, with the lowest EPS forecast at -$2.65, and the highest EPS forecast at -$2.84. In 2027, PLUR's EPS is forecast to hit -$1.94 (min: -$1.86, max: -$2.00).

What is PLUR's forecast return on equity (ROE) for 2026-2027?

(NASDAQ: PLUR) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.